Evidence map›Paper›PMID 30543181›Full record

ArticleeLife2018

Structured illumination microscopy combined with machine learning enables the high throughput analysis and classification of virus structure.

Romain F Laine, Gemma Goodfellow, Laurence J Young, Jon Travers, Danielle Carroll, Oliver Dibben, Helen Bright, Clemens F Kaminski

Abstract read
In one paragraph

Article in eLife, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed.

  1. Implications of morphological variation in influenza viruses.Microbiology and molecular biology reviews : MMBR · 2025
    Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Virus morphology: Insights from super-resolution fluorescence microscopy.Biochimica et biophysica acta. Molecular basis of disease · 2022
    Review
  15. Article
  16. Review
  17. Review
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Romain F LaineDepartment of Chemical Engineering and Biotechnology, University of Cambridge, Cambridge, United Kingdom.ORCID http://orcid.org/0000-0002-2151-4487
Gemma GoodfellowDepartment of Chemical Engineering and Biotechnology, University of Cambridge, Cambridge, United Kingdom.
Laurence J YoungDepartment of Chemical Engineering and Biotechnology, University of Cambridge, Cambridge, United Kingdom.
Jon TraversMedImmune Ltd, Cambridge, United Kingdom.
Danielle CarrollFlu-BPD, MedImmune, Liverpool, United Kingdom.
Oliver DibbenFlu-BPD, MedImmune, Liverpool, United Kingdom.
Helen BrightFlu-BPD, MedImmune, Liverpool, United Kingdom.
Clemens F KaminskiDepartment of Chemical Engineering and Biotechnology, University of Cambridge, Cambridge, United Kingdom.ORCID https://orcid.org/0000-0002-5194-0962

Funding

Biotechnology and Biological Sciences Research Council BB/H023917/1Biotechnology and Biological Sciences Research Council BB/P027431/1Medical Research Council G0902243Medical Research Council MR/K015850/1Medical Research Council MR/K02292X/1Wellcome Trust 089703/Z/09/ZWellcome Trust 203249/Z/16/ZWellcome Trust 3-3249/Z/16/Z
6 · The paper itself

Abstract

Optical super-resolution microscopy techniques enable high molecular specificity with high spatial resolution and constitute a set of powerful tools in the investigation of the structure of supramolecular assemblies such as viruses. Here, we report on a new methodology which combines Structured Illumination Microscopy (SIM) with machine learning algorithms to image and classify the structure of large populations of biopharmaceutical viruses with high resolution. The method offers information on virus morphology that can ultimately be linked with functional performance. We demonstrate the approach on viruses produced for oncolytic viriotherapy (Newcastle Disease Virus) and vaccine development (Influenza). This unique tool enables the rapid assessment of the quality of viral production with high throughput obviating the need for traditional batch testing methods which are complex and time consuming. We show that our method also works on non-purified samples from pooled harvest fluids directly from the production line.

Indexed as

Machine LearningAlgorithmsAutomationImage Processing, Computer-AssistedInfluenza VaccinesMicroscopy, FluorescenceNewcastle disease virusOrthomyxoviridaeVaccines, AttenuatedInfluenza VaccinesVaccines, Attenuatedepidemiologyglobal healthinfectious diseaseInfluenzamachine learningmicrobiologyNewcastle disease virusstructural analysissuper-resolution microscopyvirus

Identifiers

PMID30543181
PMCPMC6331195

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.